Inventor · disambiguated record
Anke Geick
Also filed as: GEICK ANKE
28 granted patents·14 pending applications·907 citations·filing 2003–2023
97Inventor score
Files withALNYLAM PHARMACEUTICALS INC13ARROWHEAD PHARMACEUTICALS INC5AXOLABS GMBH4NAKAYAMA TOMOKO4NOVARTIS AG3
Top patents by PatentIndex Score
42 records- 0199US7718629B2Compositions and methods for inhibiting expression of Eg5 geneALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted May 18, 2010·241 cites·33 claims
- 0299US7582745B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Sep 1, 2009·152 cites·11 claims
- 0396US9433681B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2014·Granted Sep 6, 2016·24 cites·21 claims
- 0496US7718632B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2008·Granted May 18, 2010·24 cites·27 claims
- 0595US8691750B2Lipids and compositions for intracellular delivery of biologically active compoundsCONSTIEN RAINER·Filed 2012·Granted Apr 8, 2014·288 cites·13 claims
- 0695US7943592B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 17, 2011·18 cites·20 claims
- 0795US7939508B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 10, 2011·18 cites·23 claims
- 0894US9278130B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2014·Granted Mar 8, 2016·15 cites·20 claims
- 0993US8470799B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2012·Granted Jun 25, 2013·9 cites·20 claims
- 1093US8268799B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2011·Granted Sep 18, 2012·10 cites·24 claims
- 1193US8168606B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted May 1, 2012·15 cites·23 claims
- 1292US9636302B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2016·Granted May 2, 2017·6 cites·22 claims
- 1392US8791250B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jul 29, 2014·7 cites·20 claims
- 1488US7473525B2Compositions and methods for inhibiting expression of anti-apoptotic genesALNYLAM EUROPE AG·Filed 2003·Granted Jan 6, 2009·53 cites·4 claims
- 1587US9074212B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Jul 7, 2015·6 cites·20 claims
- 1687US8119612B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Feb 21, 2012·6 cites·23 claims
- 1785US8163711B2Compositions and methods for inhibiting expression of the HAMP geneNAKAYAMA TOMOKO·Filed 2010·Granted Apr 24, 2012·5 cites·19 claims
- 1884US9476052B2RNAi inhibition of alpha-ENaC expressionARROWHEAD RES CORP·Filed 2015·Granted Oct 25, 2016·2 cites·20 claims
- 1982US7906484B2Complex for transferring an anionic substance into a cellALNYLAM PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·3 cites·20 claims
- 2082US2022235361A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2181US10544418B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·1 cites·13 claims
- 2281US9090895B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·1 cites·20 claims
- 2381US2022112505A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2477US7772200B2iRNA agents targeted to the Rho-A geneALNYLAM PHARMACEUTICALS INC·Filed 2006·Granted Aug 10, 2010·2 cites·5 claims
- 2576US11208662B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Dec 28, 2021·0 cites·21 claims
- 2675US7902168B2Compositions and methods for inhibiting expression of Nav1.8 geneALNYLAM PHARMACEUTICALS INC·Filed 2009·Granted Mar 8, 2011·1 cites·11 claims
- 2770US2024150757A1Antisense oligonucleotides targeting foxg1ELIGAB TX LLC·Filed 2023·Application pending·0 cites
- 2870US2024093192A1Antisense oligonucleotides increasing foxg1 expressionELIGAB TX LLC·Filed 2023·Application pending·0 cites
- 2968US9149531B2Lipids and compositions for intracellular delivery of biologically active compoundsAXOLABS GMBH·Filed 2014·Granted Oct 6, 2015·0 cites·4 claims
- 3067US9914927B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·0 cites·20 claims
- 3167US9057069B2Compositions and methods for inhibiting expression of Eg5 geneALNYLAM PHARMACEUTICALS INC·Filed 2013·Granted Jun 16, 2015·0 cites·27 claims
- 3265US9506067B2Compositions and methods for inhibiting expression of the HAMP geneALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Nov 29, 2016·0 cites·20 claims
- 3364US2009209478A1Compositions and methods for inhibiting expression of the hamp geneNAKAYAMA TOMOKO·Filed 2007·Application pending·0 cites
- 3462US2016017337A1Compositions and Methods for Inhibiting Expression of Eg5 GeneALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3560US2012136145A1Compositions and Methods for Inhibiting Expression of Eg5 GeneBUMCROT DAVID·Filed 2011·Application pending·0 cites
- 3657US2011015250A1COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 GENEBUMCROT DAVID·Filed 2010·Application pending·0 cites
- 3752US2007197460A1Rnai inhibition of influenza virus replicationALNYLAM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3851US2011124711A1COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENEALNYLAM PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3944US2011071209A1RNAi Modulation of the RHO-A Gene and Uses ThereofALNYLAM PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4041US2011152349A1Compositions and methods for inhibiting expression of il-18 genesGEICK ANKE·Filed 2010·Application pending·0 cites
- 4138US2011196016A1Compositions and Methods for Inhibiting Expression of IKK2 GenesGEICK ANKE·Filed 2011·Application pending·0 cites
- 4238US2004121348A1Compositions and methods for treating pancreatic cancerRIBOPHARMA AG·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →